Loading...
IKZF1 deletions in pediatric acute lymphoblastic leukemia: still a poor prognostic marker?
Improved personalized adjustment of primary therapy to the perceived risk of relapse by using new prognostic markers for treatment stratification may be beneficial to patients with acute lymphoblastic leukemia (ALL). Here, we review the advances that have shed light on the role of IKZF1 aberration a...
Na minha lista:
| Udgivet i: | Blood |
|---|---|
| Main Authors: | , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
American Society of Hematology
2020
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7019035/ https://ncbi.nlm.nih.gov/pubmed/31821407 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood.2019000813 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|